Noronha, V., (2013) reported an EGFR mutation rate of 35% among NSCLC in the Indian population [15] A large-scale Asian study on adenocarcinoma patients found the overall EGFR mutation rate to be 51.4%, while it was reported to be 30% in the East Asia population,. Here, EGFR is linked to non-small cell lung carcinoma.